Showing results (181-190 of 322) with videos related to

Sort By:
Pageof 33
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Use of human leukocyte antigen-mismatched allogeneic lymphokine-activated killer cells and interleukin-2 in the adoptive immunotherapy of patients with malignanciesY Kimoto, T Tanaka, Y Tanji, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Semi-synthesis of polymyxin-B conjugated ovalbumin: evaluation of lipopolysaccharide binding avidity and neutralization of induced tnf-alpha synthesisC P Coyne, J T Moritz, V C Langston
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Immunogenicity of recombinant human interleukin-2: biological features and clinical relevanceE L Hänninen, J Knüver-Hopf, J Atzpodien
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Mast cell growth factor (C-kit ligand) in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3: in vivo hemopoietic effects in irradiated mice compared to in vitro effectsM L Patchen, R Fischer, T J MacVittie, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
The presence of a common antigen between human gastric cancer cells and OK-432K Ogawa, T Katsube, M Hirai, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Systemic IL-1 and adjuvant treatment of an experimental tumor. II. Immune status during primary tumor challengeS M Kiertscher, H L Mathews
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Lymphocyte responses to food antigens in food sensitive patients with allergic tension-fatigue syndromeN Kondo, S Shinoda, H Agata, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Somatostatin and growth hormone regulation in cancerA Manni
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Studies on NK cell purification by negative selection in human peripheral bloodF Farace, A M Le Ridant, B Escudier, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusionT Hori, K Mise, N Kan, et al.
Pageof 33